05.22.25 -- Hard Lessons In Parenteral Automatic Visual Inspection

Discover how scalable innovation is transforming viral vector production and driving broader, more equitable access to advanced gene therapies.

Discover how LNPs revolutionize intracellular drug delivery to enhance RNA vaccines, cell therapies, protein replacement, and gene editing.

Learn about a novel solution dramatically improving the purification and yield of promising nanoscale vesicles for medical applications.

Discover how TFDF-based perfusion technology boosts lentiviral vector production by over 10-fold, slashes costs, and accelerates the commercialization of CAR-T and other advanced cell therapies.

Learn how this game-changing platform simplifies the complex process of custom media design, empowering researchers to expedite their development and achieve optimal results.

Discover key findings that highlight the importance of evaluating LVV stability to develop a robust purification process. 

Data from the use of two distinct methods to generate billions of gamma delta T cells from peripheral blood mononuclear cells (PBMCs) is compared.

Here, we outline a scalable and robust upstream process developed for LVV production of HEK293T cells and demonstrate how to expand HEK293T suspension cells.

Explore the use of a mini bioreactor system for stem cell culturing that optimized process parameters of a human induced pluripotent stem cell (hiPSC) culture in a step-by-step process.

Demand for single-use production tools, components, expertise, and capabilities continues to grow as innovative cell therapies evolve. However, concerns and misconceptions surround single-use solutions.